RISK FACTORS FOR SEROCONVERSION TO HUMAN IMMUNODEFICIENCY VIRUS AMONG MALE HOMOSEXUALS
- 1 February 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8529) , 345-349
- https://doi.org/10.1016/s0140-6736(87)91725-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- CAN HTLV-III BE TRANSMITTED ORALLY?The Lancet, 1986
- Human T-Lymphotropic Virus Type III in High-Risk, Antibody-Negative Homosexual MenAnnals of Internal Medicine, 1986
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985
- Antibody seronegative human T-lymphotropic virus type III (HTLV-III)- infected patients with acquired immunodeficiency syndrome or related disordersBlood, 1985
- Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.BMJ, 1984
- DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MENThe Lancet, 1984
- Kaposi's Sarcoma in Homosexual MenAnnals of Internal Medicine, 1984
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984
- Sexually Transmitted Diseases and HomosexualitySexually Transmitted Diseases, 1983
- National Case-Control Study of Kaposi's Sarcoma and Pneumocystis carinii Pneumonia in Homosexual Men: Part 1, Epidemiologic ResultsAnnals of Internal Medicine, 1983